CD8A and neoplasm: Interestingly, in the model used here, we demonstrated a strong correlation between the presence of anti-viral and tumor-specific CD8+ TILs, suggesting that VSV-NDV therapy not only does not distract from the induction of tumor-specific immunity, but it might even promote it.